The serotonin 5-HT(2C) receptor is a prominent serotonin receptor in basal ganglia: Evidence from functional studies on serotonin-mediated phosphoinositide hydrolysis

Journal of Neurochemistry

Volumn 69, Issue 4, 1997, Pages 1449-1458

  Wolf, William A ^a,b   Schutz, Laurence J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Brain; Phosphoinositide hydrolysis; Phospholipase C; Rat; Serotonin receptor

Indexed keywords

FANANSERIN; MESULERGINE; MIANSERIN; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; SEROTONIN 1C RECEPTOR; SPIPERONE; TRITIUM; CALCIUM; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PHOSPHATIDYLINOSITOL; SEROTONIN; SEROTONIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BINDING SITE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; ENZYME ACTIVITY; HYDROLYSIS; LIGAND BINDING; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC TRANSMISSION; ANIMAL; BRAIN; CAUDATE NUCLEUS; ENZYMOLOGY; FRONTAL LOBE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALIA; TRITIUM;

ANIMALS; BASAL GANGLIA; BINDING SITES; BRAIN; CALCIUM; CAUDATE NUCLEUS; FRONTAL LOBE; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HYDROLYSIS; MALE; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN;

EID: 0030610894     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69041449.x     Document Type: Article

References (54)

1. 2C receptor protein in human and rat brain using specific antisera. Neuropharmacology 34, 1635-1645.
2. 2C receptors reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 269, 11687-11690.
3. 2 serotonin receptors. Life Sci. 33, 2011-2016.
4. 2 serotonin receptors. J. Neurochem. 43, 1213-1219.
5. 1B-like receptor function via arachidonic acid metabolism. Mol. Pharmacol. 50, 1017-1023.
6. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
7. Chuang D.-M. (1990) Neurotransmitter receptors and phosphoinositide turnover. Annu. Rev. Pharmacol. Toxicol. 29, 71-110.
8. Claro E., Wallace M. A., Lee H.-M., and Fain J. N. (1989) Carbachol in the presence of guanosine 5′-O-(3-thiotriphosphate) stimulates the breakdown of exogenous phosphatidylinositol 4,5-bisphosphate, phosphatidylinositol 4-phosphate and phosphatidylinositol in rat brain membranes. J. Biol. Chem. 264, 18288-18295.
9. 2 receptors in depression. Psychiatry Res. Neuroimaging 45, 227-237.
10. 2 receptor antagonist. Br. J. Pharmacol. 105, 27-34.
11. 2C-induced oral dyskinesia. Neuroscience 72, 117-128.
12. 2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositol phospholipid hydrolysis. Proc. Natl. Acad. Sci. USA 87, 2187-2191.
13. 2 serotonin receptors. J. Med. Chem. 31, 5-7.
14. Gong L., Kostrzewa R. M., Fuller R. W., and Perry K. W. (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J. Pharmacol. Exp. Ther. 261, 1000-1007.
15. Greenwood A. F., Powers R. E., and Jope R. S. (1995) Phosphoinositide hydrolysis. Gαq, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience 69, 125-138.
16. Harrington M. A., Zhong P., Garlow S. J., and Ciaranello R. D. (1992) Molecular biology of serotonin receptors. J. Clin. Psychiatry 53(Suppl. 10), 8-27.
17. 1 recognition sites. J. Recept. Res. 8, 59-81.
18. 3H]ketanserin. Eur. J. Pharmacol. 118, 13-23.
19. 2 recognition sites. Brain Res. 376, 97-107.
20. 2 receptors in rat brain: an autoradiographic study. Synapse 14, 324-331.
21. q/11 and phospholipase C-β. Biochem. J. 304, 655-659.
22. Jope R. S., Song L., Li P. P., Young L. T., Kish S. J., Pacheco M. A., and Warsh J. J. (1996) The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J. Neurochem. 66, 2402-2409.
23. Kapur S. and Remington G. (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am. J. Psychiatry 153, 466-476.
24. Kendall D. A. and Nahorski S. R. (1985) 5-Hydroxytryptamine-stimulated inositol phospholipid hydrolysis in rat cerebral cortex slices: pharmacological characterization and effects of antidepressants. J. Pharmacol Exp. Ther. 233, 473-479.
25. 1C receptors and their therapeutic relevance. Curr. Opin. Invest. Drugs 2, 317-362.
26. 1C receptors. Br. J. Pharmacol. 94, 137-147.
27. 1C receptors mediate 1-3(chlorophenyl) piperazine-induced hypophagia. Br. J. Pharmacol. 103, 2016-2020.
28. 2B receptor antagonist, in two conflict models of anxiety. Psychopharmacology (Berl.) 118, 178-182.
29. 6 serotonin receptor. J. Neurochem. 66, 47-56.
30. 2C receptors in the rat choroid plexus after acute clozapine treatment. Eur. J. Pharmacol. Mol. Pharmacol. 269, 201-208.
31. 2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. Neuropsychopharmacology 13, 139-150.
32. 2 receptors. Mol. Pharmacol. 42, 328-335.
33. Lucki I., Ward H. R., and Frazer A. (1989) Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethyl)piperazine on locomotor activity. J. Pharmacol. Exp. Ther. 249, 155-164.
34. 2 receptor antagonist: in vitro and ex vivo selectivity profile. Eur. J. Pharmacol. 233, 29-35.
35. 3H]RP 62203 binding in the rat brain. Eur. J. Pharmacol. 233, 37-45.
36. Meltzer H. Y. and Nash J. F. (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacol. Rev. 43, 587-604.
37. 1C receptor is a prominent serotonin receptor subtype in the central nervous system. Proc. Natl. Acad. Sci. USA 86, 6793-6797.
38. Monsma F. J. Jr., Shen Y., Ward R. P., Hamblin M. W., and Sibley D. R. (1993) Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43, 320-327.
39. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney.
40. Pazos A. and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346, 205-230.
41. Pazos A., Cortes R., and Palacios J. M. (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res. 346, 231-249.
42. Plech A., Brus R., Kalbfleisch J. H., and Kostrzewa R. M. (1995) Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Psychopharmacology (Berl.) 119, 466-473.
43. 2C receptors. Mol. Brain Res. 23, 163-178.
44. 3H]mesulergine binding. J. Pharmacol. Exp. Ther. 261, 161-165.
45. Raaflaub J. (1956) Applications of metal buffers and metal indicators in biochemistry, in Methods of Biochemical Analysis, Vol. III (Glick D., ed), pp. 301-325. Interscience Publishers, New York.
46. Rupniak N. M. J., Jenner P., and Marsden C. D. (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berl.) 88, 403-419.
47. Sanders-Bush E., Tsutsumi M., and Burris K. D. (1990) Serotonin receptors and phosphatidylinositol turnover. Ann. NY Acad. Sci. 600, 224-236.
48. Titeler M., Lyon R. A., Davis K. H., and Glennon R. A. (1987) Selectivity of serotonergic drugs for multiple brain serotonin receptors. Biochem. Pharmacol. 36, 3265-3271.
49. Van de Kar L. D. (1991) Neuroendocrine pharmacology of serotonergic (5-HT) neurons. Annu. Rev. Pharmacol. Toxicol. 31, 289-320.
50. Van Wijngaarden I., Tulp M. T. M., and Soudijn W. (1990) The concept of selectivity in 5-HT receptor research. Eur. J. Pharmacol. Mol. Pharmacol. 188, 301-312.
51. Waddington J. L. (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology (Berl.) 101, 431-447.
52. Wolf W. A. (1996) Serotonin receptor-mediated phospholipase C activity in rat brain membranes: differential effects of mCPP. Soc. Neurosci. Abstr. 22, 1779.
53. Wolf W. A. and Bobik A. (1989) Alpha methyldopa metabolism in central serotonergic nerve terminals: effects on serotonin levels, synthesis and release. Eur. J. Pharmacol. 163, 43-53.
54. 2 receptor changes in major depression. Biol. Psychiatry 27, 489-496.